
Track key moves in stocks like Swiggy, Infosys, and HCLTech with updates on deals, contracts, and acquisitions—see the latest market…
Track Nifty as Trump’s tariff threats shake its recovery, pharma rallies, and metals falter – see how markets may move…
Track top stocks like Bharti Airtel, Lupin, and NSDL today as earnings and key IPOs drive market action-see which stocks…
Stocks to watch today, July 29: GIFT Nifty indicates a subdued start for domestic indices. Here are the top stocks…
Torrent Pharma reported 11% YoY revenue growth in Q1FY26 to Rs 3,178 crore, with PAT rising 20% to Rs 548…
Markets remain cautious ahead of earnings; track Tata Steel, JSW Steel, and Cipla for breakout moves this week.
Torrent Pharma will emerge among the top 5 domestic pharma players by sales with the acquisition of J B Chemicals…
Motilal Oswal maintains ‘Neutral’ on Torrent Pharma with a Rs 3,430 target; review their three key concerns before you invest.
Stocks to watch today, June 30: GIFT Nifty indicates a lower start for domestic indices. Here are the top stocks…
Jefferies recommends Buy on DLF, CMS Info Systems, and Torrent Pharma, citing strong fundamentals and growth prospects. Check updated target…
According to AWACS MAT April 2024 data, the Indian market for treatments used in GERD is valued at INR 8,064…
Torrent Pharma posted revenue from operations at Rs 2732 crore, up 9.7 per cent as against Rs 2491 crore during…
Torrent Pharma’s share price dropped by nearly 4% amid reports of its intention to acquire a controlling stake in Cipla.
The estimated project cost of the 132 MW project is Rs 700 Crores.
Revenue from operations rose to Rs 2,291 crore in the July-September quarter as against Rs 2,137 crore in the year-ago…
The acquisition will strengthen Torrent Pharma’s presence in the dermatology segment.
On Friday, Torrent Pharma reported a 7 percent increase in its consolidated net profit to Rs 354 crore for the…